Prostate Cancer Screening: Why PSA Alone Leaves Questions Open
PSA is a useful screening tool, but it is not specific to cancer. Prostate specific antigen can rise from an enlarged prostate, inflammation, infection, recent cycling, and age itself, which is why an elevated result so often leads to more testing rather than a clear answer.
September is Prostate Cancer Awareness Month, and at resTOR Longevity Clinic in Houston, Texas, prostate screening pairs PSA with epigenetic biomarkers to narrow that ambiguity.
What PSA Does and Does Not Tell You
PSA measures a protein produced by prostate tissue. Higher levels can indicate a problem, but the test does not distinguish between causes, and cancer is only one of several.
The practical result is familiar to a lot of men over 50. A borderline number leads to a repeat draw, then a watchful waiting period, then possibly a biopsy that comes back negative.
- PSA can be elevated without cancer being present
- PSA can be unremarkable in some men who do have prostate cancer
- Levels tend to rise naturally with age and prostate size
- A single value carries far less meaning than a trend over time
What Epigenetic Biomarkers Add
Epigenetics refers to chemical modifications that sit on top of DNA and influence whether genes are switched on or off. Those patterns can shift in the presence of disease activity, which makes them useful as a signal.
In prostate screening, epigenetic biomarkers are used alongside PSA to add specificity. Rather than asking only how much antigen is present, the combination asks whether the underlying tissue is behaving abnormally.
That does not replace PSA and it does not replace clinical judgment. It gives the physician a second, independent line of information before recommending an invasive next step.
Who Should Be Screening, and When
Screening decisions are individual, and appropriate timing depends on personal and family history. Broadly, the conversation tends to begin earlier for men with additional risk factors.
- Men in their forties are generally old enough to start the discussion
- A father or brother with prostate cancer raises the priority of early screening
- Known inherited variants may change the recommended starting age
- Men of African ancestry are affected at higher rates and often benefit from earlier discussion
Whether screening is appropriate for you, and at what interval, is a decision to make with a physician rather than from a checklist.
How Prostate Screening Fits Into OptiMan
Prostate screening at resTOR is part of the broader men's health evaluation in the OptiMan program, not an isolated test. That matters because prostate health sits alongside hormone status, metabolic health, and cardiovascular risk.
Dr. Gregory Burzynski, MD reviews prostate results in that fuller context, and inherited risk is informed by the genetic testing included in the Core and Essential programs.
Men from The Heights, Spring Valley, and across Houston typically complete this alongside the rest of their assessment day.
"The problem with PSA was never that it is a bad test. It is that we asked one number to carry too much weight. Adding an independent signal means fewer men sitting in limbo waiting to find out what an elevated result meant," says Dr. Gregory Burzynski, MD.
Frequently Asked Questions
At what age should I start prostate cancer screening?
Most discussions begin somewhere in the forties, and earlier when there is family history or other known risk factors. Because screening decisions involve individual tradeoffs, the appropriate starting age is best determined with a physician who knows your history.
Does a high PSA mean I have prostate cancer?
Not by itself. PSA can rise due to an enlarged prostate, inflammation, infection, or age. An elevated result indicates that further evaluation is warranted, not that cancer is present. Pairing PSA with additional markers helps clarify what is driving the number.
Can screening replace a biopsy?
No. Screening tests indicate whether further investigation is appropriate. A biopsy remains the method for establishing a diagnosis. Better screening information is intended to help determine who genuinely needs that step.
Make Prostate Cancer Awareness Month Useful
If prostate screening is something you have postponed, or if a past PSA result left you without a clear answer, resTOR Longevity Clinic in Houston, Texas can walk you through the options. Contact the resTOR team to schedule a consultation.
Published by resTOR Longevity Clinic | Dr. Gregory Burzynski | Serving Houston and Harris County, TX | (832) 968-7531
Educational purposes only. Not medical advice.
